Regulatory & Legal

A German court just handed Emboline a major victory, serving as a stark warning to IP infringers and clearing a path for its innovative heart device.

The U.S. Fish and Wildlife Service again denied a petition to list long-tailed macaques as endangered, a move hailed by researchers but decried by activists.

A catastrophic crash, a life destroyed. A $2.6M settlement reveals how a trucking firm's negligence, from a failed background check to a broken safety system, led to tragedy.

As the largest wild horse roundup in Nevada history begins, a clash over taxpayer costs, animal welfare, and innovative solutions ignites a national debate.

A lawsuit alleges Target knew its exclusive water bead toys were a deadly risk but failed to warn parents, leading to a toddler's tragic death.

A wrongful death lawsuit for Officer Patricia Espinosa exposes the fragile network of laws meant to prevent tragedy. Who is truly accountable?

As biotech firm Seer secures key patent wins, it's not just defending its tech—it's drawing the battle lines for the multi-billion dollar proteomics market.

A breakthrough melanoma test from SkylineDx has earned rare dual recognition, promising to reshape patient care by reducing unnecessary surgeries.

A lawsuit alleging a violent assault during a DoorDash alcohol delivery raises critical questions about gig platform liability and the hidden risks of convenience.

Tour operator Novaturas must pay a massive penalty after a court ruling on a COVID-era contract, highlighting the pandemic's lasting financial toll on the travel sector.

A lawsuit alleges top officials at the Mental Health Association of Nassau County sexually exploited, financially manipulated, and retaliated against a client.

A high-stakes lawsuit accuses the EU of supporting democratic erosion in Armenia, placing Brussels' foreign policy and geopolitical strategy under intense scrutiny.

A Chinese court cleared Biocytogen’s core antibody platform, a ruling that is less about one patent and more about validating a new era of sovereign innovation.

The high court's 7-2 decision on Roundup not only ends a legal saga for Bayer but signals a major shift in product liability across all federally regulated industries.

A lawsuit alleges a doctor was punished for prioritizing patient need over a VIP. The case exposes deep tensions in medical training, ethics, and leadership.

A bitter dispute between Solmate Infrastructure and its top investor, RockawayX, exposes deep governance flaws and the volatile intersection of finance and crypto.

Vaxart’s COVID pill vaccine trial sees funding cut, yet new funds for data analysis signal a complex bet by BARDA on the future of pandemic response.

A £1.3M debt dispute escalates as the National Bank of Uzbekistan pursues Solfy CA in English courts, alleging a smear campaign to derail justice.

Valgen Medtech's dual EU approval for its heart valve device isn't just a clinical win; it's a tremor in the global medical technology landscape.

CEA Industries reports a $115M profit, but a $130M crypto loss and a lawsuit against its own asset manager reveal the volatile reality of its BNB treasury.